Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 355

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 355
---
 the Business Combination, especially the sections entitled “The Business Combination,” “ The Business Combination Agreement” and “ Certain Agreements Related to the Business Combination” beginning on pages 122, 139 and 156, respectively. In particular, you are directed to the Business Combination Agreement, which is attached as Annex A to this proxy statement/prospectus. Resolution to be Voted Upon The full text of the resolution to be proposed is as follows: “RESOLVED, as an ordinary resolution, that the Company’s entry into the Business Combination Agreement, dated as of March 25, 2024 (as the same has been or may be amended, modified, supplemented or waived from time to time, the “Business Combination Agreement”), by and among the Company, OmnigenicsAI Corp, a Cayman Islands exempted company (“OmnigenicsAI”), Heritas Merger Sub Limited, a Cayman Islands exempted company and a direct wholly -ownedsubsidiary of OmnigenicsAI (“Merger Sub”) and MultiplAI Health Ltd, a limited company formed under the laws of England and Wales (“MultiplAI”), pursuant to which, among other things, Merger Sub will merge with and into the Company (with the Company being the surviving company and a direct wholly -ownedsubsidiary of OmnigenicsAI) in exchange for shareholders of the Company receiving merger consideration consisting of ordinary shares of par value $0.0001 each of OmnigenicsAI (“Company Shares”) and warrants to purchase Company Shares.” Vote Required for Approval This Business Combination Proposal (and consequently, the transactions contemplated by the Business Combination Agreement, including the Business Combination) requires an ordinary resolution under APx’s Existing Governing Documents, being the affirmative vote of the holders of a simple majority of the ordinary shares who, being present in person or by proxy and entitled to vote at the Special Meeting, vote at the Special Meeting. Failure to submit a proxy or to vote in person or virtually at the Special Meeting, or an abstention from voting, will have no effect on the Business Combination Proposal. The Closing is conditioned on the adoption of the Business Combination Proposal. The Business Combination Proposal is conditioned upon the adoption of the Cayman Merger Proposal. Recommendation of the APx Board THE APX BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE “FOR” THE APPROVAL OF THE BUSINESS COMBINATION PROPOSAL. 173 Proposal No. 2 — The Cayman Merger Proposal Overview In connection with